The Biggest Myth in Lesbian Sex: “We Don’t Need to Worry About STIs”

Published: May 2025 | Last updated: May 2026

The idea that women who have sex with women do not need to worry about sexually transmitted infections is one of the most persistent myths in sexual health. It can feel intuitive at first, because there is no penis or semen in the picture. The CDC’s own guidance on women who have sex with women (often shortened to WSW) tells a different story, and so does the NHS guidance for lesbian and bisexual women. Many STIs spread through skin contact, mucous-membrane contact, shared fluids, and shared toys, which means cisgender women, transgender women, and nonbinary people whose partners are women can absolutely pass infections to each other.

This article walks through what the public-health evidence says about transmission between female partners, where the medical system has historically failed queer women, and what a reasonable testing plan looks like for someone whose partners are women.

Why the “no risk” myth lasted so long

If you grew up queer or questioning, your sex education probably had a sentence-long mention of “using protection” that quietly assumed a male partner. Female-female intimacy was usually skipped entirely, with no mention of dental dams, barriers on toys, or which infections spread without intercourse. The omission reflects how public-health curricula were built around heterosexual transmission and treated everything else as a footnote.

Older epidemiology compounded the problem. Through the 1990s and into the 2000s, STI surveillance focused on cervical-cancer screening and heterosexual transmission, with very little data on women whose partners were exclusively women. The U.S. Centers for Disease Control and Prevention now addresses WSW as a population that does acquire and transmit a wide range of STIs, but that updated framing took decades to filter into clinical practice. Many providers still default to “low-risk” assumptions during a visit, especially when a patient mentions only female partners.

A generation of WSW patients were never offered routine screening, never told which barriers reduce risk, and never asked about specific practices. Without systematic data collection on female-female transmission, the misconception that nothing could pass between women had room to settle in unchallenged.

How STIs actually move between women

Most STIs do not require penetration or ejaculation to spread. They need a pathway: skin contact, contact with mucous membranes (the moist tissues lining the genitals, anus, mouth, and throat), shared body fluids, or a shared object that has touched someone’s genitals or fluids. Sex between women involves all of those pathways routinely, even in the most loving and non-penetrative encounters.

The mechanisms break down roughly as follows:

• Skin-to-skin spread. Herpes simplex virus (HSV-1 and HSV-2), human papillomavirus (HPV), syphilis, and molluscum contagiosum spread through direct contact with infected skin or mucous tissue. Visible sores are not required; HSV and HPV both shed without symptoms.
• Mucous-membrane exposure during oral sex. Pharyngeal gonorrhea, oral herpes, and HPV can all transmit between mouths and genitals in either direction.
• Fluid exchange. Trichomoniasis, chlamydia, gonorrhea, and bacterial vaginosis can move between partners through vaginal fluids, including when fluids are transferred via fingers or shared toys.
• Shared toys. A dildo, vibrator, or strap-on used by one partner and then immediately by another, without a fresh condom or a wash, can carry HPV, HSV, trichomonas, and bacteria from one vagina to another.
• Blood exposure. Although female-to-female HIV transmission is rare in the published literature, contact with menstrual blood through cuts or shared toys is the mechanism the CDC cites in the few documented cases.

None of these routes require a male partner, penetration, or visible symptoms. Routine STI screening for WSW now sits in the CDC’s and NHS’s guidance precisely because the transmission routes are so undemanding.

The specific infections that matter most for WSW

Looking at the population-level evidence, four infections come up most often in studies of women who have sex with women: HPV, herpes, trichomoniasis, and bacterial vaginosis. Three of those are sexually transmitted; bacterial vaginosis is more accurately called sexually associated, but it tracks new sexual partners closely and shifts readily between female partners.

Human papillomavirus (HPV)

HPV is widely described by public-health authorities as one of the most prevalent STIs. The CDC links HPV to cervical, anal, and oropharyngeal cancers and recommends routine vaccination through age 26 (with shared clinical decision-making through age 45). It spreads through skin-to-skin contact and can transfer via fingers and shared toys, not only during penetrative sex. Women whose partners are exclusively women still need routine cervical screening (pap smears or HPV co-testing on the schedule a clinician recommends), because lifelong exposure does not require a male partner.

Herpes simplex virus (HSV-1 and HSV-2)

Both HSV-1 (more common around the mouth) and HSV-2 (more common in the genital area) shed asymptomatically, which is the public-health term for the periods when the virus is on the skin or in fluids without producing any visible sore. The CDC’s herpes resources note that most people with genital herpes do not know they have it; symptoms, when they appear, are often mild enough to be mistaken for a pimple or ingrown hair. Transmission between female partners can happen through kissing, oral sex, genital-to-genital contact, or shared toys.

Trichomoniasis

Trichomonas vaginalis is a single-celled parasite. The CDC’s trichomoniasis resources state that most infections produce no symptoms, with roughly 70 percent of cases going unnoticed in the patient. It can survive on fingers and on toys for short periods and has been documented as transmitting between female partners, though it is more commonly acquired from male partners. Itching, change in discharge, and irritation are the classic symptoms when they do appear. Many providers do not test for trich routinely, so this is one to ask about specifically.

Bacterial vaginosis (BV)

BV is not strictly an STI, but it behaves like one in WSW couples. Sharing vaginal flora through fingers, toys, or unprotected contact appears to drive concordance rates between female partners. The CDC’s WSW guidance specifically mentions BV as a recurrent concern; treating one partner without treating the other often leads to reinfection.

Trichomoniasis Rapid Test Kit

Trichomoniasis At-Home Rapid Test Kit

$59.00

Self-collected vaginal swab, lateral-flow result in about 15 minutes. Validated for female anatomy only; male partners who need a trichomoniasis test should see a clinic. A reasonable layer between annual visits when symptoms are vague or after a new partner.

Order Trichomoniasis Test

Toys, hands, and the “just oral” assumption

Sex between women is often more varied than sex education ever described. Oral, mutual touching, vibrators, dildos, plugs, strap-ons, and shared toys are all routine, and so are practices that switch between vaginas and other body parts within a session. Every one of those acts has a small but real route for an STI to move.

Oral sex sits at the center of a lot of misconceptions. Many people frame it as low-risk or risk-free, which is partly true and partly off. The risk of HIV transmission via oral sex is genuinely very low. Risk of acquiring or passing herpes, HPV, gonorrhea, chlamydia, and syphilis through oral-genital contact is not zero, and the WHO’s STI fact sheet lists oral contact among the documented transmission routes. Pharyngeal (throat) gonorrhea, in particular, often goes undetected because most people do not request a throat swab and the infection is frequently silent.

Shared toys carry the same considerations as shared genital contact. Using a condom on a toy, changing it between partners, or designating separate toys for separate people are simple barrier strategies that reduce transmission of HPV, HSV, trichomonas, and bacterial-vaginosis-associated bacteria. Hands carry a smaller but real risk; washing between body parts (vagina, anus, mouth) and between partners is a quick, low-effort hygiene step that meaningfully reduces movement of fluids.

None of this means every encounter needs to be treated like a clinical procedure. Those same barriers and routines from heterosexual sex education apply, with small adjustments, to WSW practice.

Why your doctor may not have asked the right questions

If you have ever told a primary-care doctor that you sleep only with women and watched them visibly relax, you have seen the WSW clinical blind spot in real time. The default assumption in many primary-care settings is still that female-female sex means low risk, which gets translated into no testing. The result, as the CDC’s own WSW guidance points out, is that WSW patients are routinely under-screened.

Several drivers keep this pattern in place:

• Clinician training on STI screening still focuses on heterosexual transmission as the default model.
• Sexual-history questions often stop at orientation, when the relevant variable is sexual practices: oral, vaginal, anal, toys, fingers.
• Patients sometimes hesitate to volunteer specific practices, especially in front of a provider who has not signaled it is a safe question.
• STI panels are often ordered as “the standard panel” without a discussion of which sites (vagina, throat, rectum) to swab, so infections at non-default sites get missed.

Improvement sits on both sides, with clinicians and patients sharing the load. Clinicians are increasingly trained to ask about specific practices, and most patients still benefit from being prepared to advocate. Saying “I have oral and genital contact with partners, and I would like vaginal-swab and throat-swab testing along with bloodwork” is a concrete, specific ask that any clinic can act on.

Building a testing plan that fits WSW practice

There is no single right cadence for STI testing, and the CDC’s guidance is deliberately practice-based rather than identity-based. A reasonable baseline for most WSW patients looks like this:

• Annual STI screening, regardless of how stable the partnership feels. This catches asymptomatic HPV, HSV, trichomoniasis, and BV early.
• A new screen when you change partners, ideally before resuming unbarriered contact with the new partner. Both partners testing in the same window is the strongest signal you have.
• Symptom-driven testing, any time you notice itching, new discharge, sores, pelvic pain, or unusual bleeding. Do not wait for an annual.
• Cervical-cancer screening (pap or HPV co-test) on the schedule your clinician recommends, regardless of partner gender. The U.S. Preventive Services Task Force and the CDC are consistent that WSW need cervical screening on the same cadence as women whose partners are men.
• Site-specific swabs. If you give or receive oral sex regularly, ask for a throat swab in addition to the vaginal swab and blood tests.

At-home rapid tests, including the lateral-flow kits sold on this site, are useful as a screening layer between clinic visits or as a privacy-preserving first step. They are screening tools rather than laboratory NAAT (nucleic acid amplification) tests, which remain the higher-sensitivity option for confirming a positive or working up a suspicious symptom. A positive at-home rapid result is worth following up with a clinic for treatment and confirmatory testing where indicated.

Women’s 10-in-1 At-Home STI Screen

Women’s 10-in-1 STD At-Home Rapid Test Kit

$590.00

Rapid lateral-flow panel covering the 10 most common STIs in one kit, in a configuration validated for female anatomy. A useful annual screening layer between clinic visits when you want broad coverage in one sitting; confirm any positive result at a clinic.

View 10-in-1 Kit

Women who have sex with women are at risk for acquiring bacterial, viral, and protozoal STIs from current and previous partners, both female and male. Risk depends on the specific sexual practices and on the prevalence of STIs within partners’ sexual networks.

Five myths, briefly

To make the picture portable, here are the five most common claims this article pushes back on, with the short version of what the evidence says:

• “Two women cannot give each other STIs.” Skin, mucous-membrane, and fluid contact all transmit infections regardless of partner gender. HPV, HSV, trich, and BV are the most consistent risks in WSW data.
• “You only need to test if you have had sex with a man.” Lifetime sexual history matters, and current-relationship transmission is well-documented in female-female couples for HPV, HSV, and trich. Testing is practice-based, not orientation-based.
• “No symptoms means no infection.” Most STIs are asymptomatic in people with vaginas, especially in early stages. Screening exists because feeling fine is not diagnostic.
• “Oral sex is safe.” Lower-risk for some infections (HIV), real-risk for others (gonorrhea, HSV, HPV, syphilis). The lower-risk framing got overgeneralized in pop culture into a no-risk framing, which is inaccurate.
• “We are both clean.” “Clean” is a casual word that does not document anything specific. Two recent negative STI panels with no new exposures since the testing window is what “safe to drop barriers” concretely means. The distinction matters when planning to stop using condoms or other barriers in a new relationship.

What to do this week

If you have been operating under the “we are both fine” assumption for a while, the most useful first step is also the smallest: book or order a baseline STI panel, even if you are in a stable, long-term partnership. Setting a known starting line, informationally rather than accusatorially, matters. A clean panel today gives you concrete information to plan around, and a positive finding caught early gives you a foothold to act on.

From there, normalize testing between partners and after any new sexual contact, ask your clinician specifically for vaginal-swab plus throat-swab plus bloodwork when relevant, and keep cervical-cancer screening on the regular schedule. Routine testing can become as unremarkable a part of WSW care as contraception counseling has become in heterosexual care.

1. U.S. Centers for Disease Control and Prevention. STI Treatment Guidelines, dedicated section on women who have sex with women, covering risk, screening, and clinical recommendations.
2. U.S. Centers for Disease Control and Prevention. Human papillomavirus (HPV) overview, including HPV-linked cancers, transmission, vaccination, and cervical screening recommendations.
3. U.S. Centers for Disease Control and Prevention. Genital herpes overview, asymptomatic shedding, and partner counseling.
4. U.S. Centers for Disease Control and Prevention. Trichomoniasis overview, asymptomatic prevalence, and screening recommendations.
5. World Health Organization. Sexually transmitted infections fact sheet, with global transmission routes and risk-reduction guidance.
6. UK National Health Service. Sexual health for lesbian and bisexual women, with practical screening and barrier guidance.

Sam Harper

Sam covers at-home sexual-health testing, public-health guidance, and clinical-testing basics for general audiences. Has been writing about consumer health since 2019, with a focus on translating CDC and WHO guidance into plain-English action items. Not a clinician; articles are summaries, not advice.